Skip to main content
. Author manuscript; available in PMC: 2019 Nov 9.
Published in final edited form as: Leukemia. 2019 May 9;33(11):2599–2609. doi: 10.1038/s41375-019-0477-x

Figure 2:

Figure 2:

Figure 2:

Disease-free survival by alloHCT or CT stratified by intermediate or poor cytogenetic categories and 5-year point estimates (2A), overall survival by alloHCT or CT stratified by intermediate or poor cytogenetic categories and 5-year point estimates (2B).